Leviathan Announces Further Increase to Previously Announced Brokered Private Placement to $12.9 Million
November 30, 2020 07:57 ET
|
Fosterville South Exploration Ltd
VANCOUVER, British Columbia, Nov. 30, 2020 (GLOBE NEWSWIRE) -- Fosterville South Exploration Ltd. (TSX-V:FSX) is pleased to announce today that, due to strong demand, Leviathan Gold Finance Ltd....
Routemaster Capital Forms and Strengthens Advisory Board With Former Executive at Alibaba Group and Yahoo!, Trapp Lewis
November 26, 2020 08:00 ET
|
Routemaster Capital Inc.
TORONTO, Nov. 26, 2020 (GLOBE NEWSWIRE) -- Routemaster Capital Inc. (the “Company” or “Routemaster”) (TSXV: RM) is pleased to announce it has appointed Trapp Lewis, former senior executive at...
Leading Healthcare Supply Chain Management Company Coldchain Technology Services Partners with Draganfly
November 25, 2020 09:15 ET
|
Draganfly Inc
Coldchain Technology Services Purchases an Initial 4 Vital Intelligence Assessment Units Los Angeles, CA., Nov. 25, 2020 (GLOBE NEWSWIRE) -- Draganfly Inc. (OTCQB: DFLYF) (CSE: DFLY) (FSE: 3U8)...
Cornerstone Announces Increased Financing to up to $7.7 Million
November 25, 2020 08:58 ET
|
Cornerstone Capital Resources Inc.
Not for distribution to United States newswire services or for dissemination in the United States OTTAWA, Nov. 25, 2020 (GLOBE NEWSWIRE) -- Cornerstone Capital Resources Inc. (“Cornerstone” or “the...
Basilea gibt Annahme von Pfizers Antrag auf Marktzulassung des Antimykotikums Isavuconazol (Cresemba®) bei invasiver Aspergillose zur regulatorischen Prüfung in China bekannt
November 25, 2020 01:15 ET
|
Basilea Pharmaceutica AG
Zweite Indikation zusätzlich zu Mukormykose in Prüfung Basel, 25. November 2020 Basilea Pharmaceutica AG (SIX: BSLN) gab heute bekannt, dass der von ihrem Lizenzpartner Pfizer Inc. (NYSE: PFE,...
Basilea reports acceptance for regulatory review of Pfizer’s marketing authorization application for antifungal isavuconazole (Cresemba®) in invasive aspergillosis in China
November 25, 2020 01:15 ET
|
Basilea Pharmaceutica AG
Second indication under review following mucormycosis Basel, Switzerland, November 25, 2020 Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that the marketing authorization application (MAA)...
Cornerstone Announces up to $6.9 Million Financing
November 24, 2020 17:43 ET
|
Cornerstone Capital Resources Inc.
Not for distribution to United States newswire services or for dissemination in the United States OTTAWA, Nov. 24, 2020 (GLOBE NEWSWIRE) -- Cornerstone Capital Resources Inc. (“Cornerstone” or “the...
Leviathan Announces Increase to Previously Announced Brokered Private Placement to $9.9 Million
November 19, 2020 14:59 ET
|
Fosterville South Exploration Ltd
VANCOUVER, British Columbia, Nov. 19, 2020 (GLOBE NEWSWIRE) -- Fosterville South Exploration Ltd. (TSX-V:FSX) is pleased to announce today that, due to strong demand, Leviathan Gold Finance Ltd....
Key COVID-19 Symptom, Oxygen Saturation Now Measurable Via Camera Utilizing Draganfly’s Vital Intelligence Assessment Technology
November 19, 2020 09:15 ET
|
Draganfly Inc
As seen with President Trump measuring Oxygen Saturation, SpO2 is key in screening and managing COVID-19 symptoms Los Angeles, CA, Nov. 19, 2020 (GLOBE NEWSWIRE) -- Draganfly Inc. (OTCQB:...
Fosterville South Receives Final Approval of the Court for Spinout of Leviathan Gold Ltd. Shares to Fosterville South Shareholders
November 19, 2020 08:58 ET
|
Fosterville South Exploration Ltd
VANCOUVER, British Columbia, Nov. 19, 2020 (GLOBE NEWSWIRE) -- Fosterville South Exploration Ltd. (“FSX” or the “Company”) (TSXV: FSX) (OTC: FSXLF) (Germany: 4TU) announces that it has received the...